Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of dihydrochromone skeleton compound in preparation of medicine for treating malignant tumors

A skeleton compound, dihydrochromone technology, applied in anti-tumor drugs, drug combinations, pharmaceutical formulations, etc., can solve the problems of not revealing biological activity, not revealing anti-tumor activity, tumor cell killing effect, etc., and achieve great social benefits and economic effects

Inactive Publication Date: 2014-10-22
SICHUAN UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the patent did not disclose the biological activity of such compounds, let alone their anti-tumor activity and killing effect on tumor cells

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of dihydrochromone skeleton compound in preparation of medicine for treating malignant tumors
  • Application of dihydrochromone skeleton compound in preparation of medicine for treating malignant tumors
  • Application of dihydrochromone skeleton compound in preparation of medicine for treating malignant tumors

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Embodiment 1: Preparation of dihydrochromone skeleton compound CPQ-16

[0030] In the reaction tube, add 0.02mmol hexahydropyridine catalyst and 0.1mmol chromone electron-deficient diene compound successively, namely 0.2mmol long-chain alkenal, namely 0.02mmol acidic additive o-fluorobenzoic acid and 1mL solvent 1,4-dioxane were reacted under normal pressure and 25°C under stirring, and the reaction was monitored by TLC. After 12 hours, the reaction was completed. The solvent was recovered under reduced pressure, and the residue was passed through The target product CPQ-16 was obtained by column chromatography separation with a yield of 68%. The structural formula is as follows:

[0031]

[0032] 1 H NMR (400MHz, CDCl 3):δ=8.04(dd,J=8.8Hz,J=6.4Hz,1H),7.19(s,1H),6.82(td,J=8.4Hz,J=2.4Hz,1H),6.67(dd,J =10.0Hz,J=2.4Hz,1H),5.15(s,1H),4.57(s,1H),4.38(dd,J=10.0Hz,J=2.8Hz,1H),4.21(q,J=7.2 Hz,2H),2.27(dd,J=13.6Hz,J=8.0Hz,1H),2.12-2.05(m,1H),1.97-1.94(m,4H),1.70(s,3H),1...

Embodiment 2

[0033] Embodiment 2: Preparation of dihydrochromone skeleton compound CPQ-17

[0034] In the reaction tube, add 0.02mmol hexahydropyridine catalyst and 0.1mmol chromone electron-deficient diene compound successively, namely 0.2mmol long-chain alkenal, namely 0.02mmol acidic additive o-fluorobenzoic acid and 1mL solvent 1,4-dioxane were reacted under normal pressure and 25°C under stirring, and the reaction was monitored by TLC. After 12 hours, the reaction was completed. The solvent was recovered under reduced pressure, and the residue was passed through The target product CPQ-17 was separated by column chromatography with a yield of 73%. The structural formula is as follows:

[0035]

[0036] 1 H NMR (400MHz, CDCl 3 ):δ=7.74(s,1H),7.20(s,1H),6.76(s,1H),5.16-5.14(m,1H),4.56(dd,J=8.0Hz,J=1.6Hz,1H) ,4.31(dd,J=10.0Hz,J=3.2Hz,1H),4.21(q,J=7.2Hz,2H),2.28(s,3H),2.24-2.22(m,4H),2.09-1.92( m,5H),1.70(s,3H),1.61(s,3H),1.55(dd,J=13.2Hz,J=3.2Hz,1H),1.40(dt,J=13.6Hz,J=2.8Hz, 1H...

Embodiment 3

[0037] Embodiment 3: Preparation of dihydrochromone skeleton compound CPQ-20

[0038] In the reaction tube, add 0.02mmol hexahydropyridine catalyst and 0.1mmol chromone electron-deficient diene compound successively, namely 0.2mmol long-chain alkenal, namely 0.02mmol acidic additive o-fluorobenzoic acid and 1mL solvent 1,4-dioxane were reacted under normal pressure and 25°C under stirring, and the reaction was monitored by TLC. After 12 hours, the reaction was completed. The solvent was recovered under reduced pressure, and the residue was passed through The target product CPQ-20 was obtained by column chromatography separation with a yield of 91%. The structural formula is as follows:

[0039]

[0040] 1 H NMR (400MHz, CDCl 3 ):δ=8.02(dd,J=8.8Hz,J=6.4Hz,1H),7.18(s,1H),6.81(td,J=8.4Hz,J=2.4Hz,1H),6.66(dd,J =9.6Hz,J=2.0Hz,1H),5.16-5.09(m,2H),4.56(s,1H),4.37(dd,J=10.4Hz,J=2.8Hz,1H),4.20(m,2H ),2.30-2.24(m,1H),2.10-1.96(m,9H),1.68(s,3H),1.60-1.54(m,7H),1.43-1.38(m,1H),1...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses applications of dihydro chromone framework compounds of CPQ-16, CPQ-17, CPQ-20, CPQ-22, CPQ-23 and CPQ-24 in preparing medicine for curing malignant tumors. According to experimental proof, any kind of the six compounds can kill a plurality kinds of tumor cells of human bodies effectively, the tumor cells comprise cervical cancer cells, non-small cell lung cancer cells, breast cancer cells, ovarian carcinoma cells, hepatoma carcinoma cells, nasopharyngeal carcinoma cells, gastric carcinoma cells, laryngocarcinoma cells, pancreatic cancer cells, melanoma cells, bladder cancer cells and leukemia cells. Besides, with increase of dosages of the compounds, injured and killed cancers are increased with the increase of the dosages, and thus the new applications are proofed and discovered in the medicine for curing malignant tumors, and a new application range is exploited. Besides, new medicine is provided for the malignant tumors, and the difficulty in the chemical treatment of diseases that tumor cells are tolerant of chemotherapeutics is solved.

Description

technical field [0001] The invention relates to the use of a dihydrochromone skeleton compound, in particular to the application of the dihydrochromone skeleton compound in the preparation of medicines for treating malignant tumors. Background technique [0002] Malignant tumor is a major disease that endangers human health, and it has become the first cause of death among Chinese residents. Chemotherapy is still the main means of treatment for many malignant tumors, but the resistance of tumor cells to chemotherapeutic drugs, including primary drug resistance and acquired drug resistance, has always been the primary problem that plagues and restricts the chemotherapy of malignant tumors in clinical practice. Therefore, it is urgent to find innovative drugs with high anticancer activity. In recent years, natural products and their derivatives have become an important source of innovative anticancer drugs. The development of Class 1 new drugs through total synthesis is of g...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/352A61P35/00A61P35/02
Inventor 王霞陈应春廖林川陈鹏桥周玉琼郑雪莲林勇李俊龙张林
Owner SICHUAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com